McCully Mark, Lipkis Julia, Heller Aryel, Huñis Adrian
PharmaValue Partners, 603 Mattison Avenue, Suite 319, Asbury Park, NJ 07712, USA.
A. Hunis & Associates, Oncology Consultants, Hollywood, FL 33019, USA.
Ecancermedicalscience. 2024 Jun 7;18:1711. doi: 10.3332/ecancer.2024.1711. eCollection 2024.
Non-muscle invasive bladder cancer (NMIBC) is characterised by high rates of recurrence and progression, requiring substantial healthcare resources. In Latin America, the incidence of NMIBC is set to increase due to an aging population and lifestyle changes. To better understand the current challenges for NMIBC treaters and patients, a mixed-methods approach was leveraged combining secondary research with qualitative interviews from healthcare providers in Brazil, Colombia, Mexico and Argentina. Our analysis found that significant challenges persist across the region, particularly due to Calmette-Guérin shortages, inconsistent adherence to clinical guidelines and significant socioeconomic disparities for patients accessing healthcare services. Addressing these challenges requires improved patient advocacy, strategic use of clinical trials and better resource distribution to enhance NMIBC management across Latin America.
非肌层浸润性膀胱癌（NMIBC）的特点是复发率和进展率高，需要大量医疗资源。在拉丁美洲，由于人口老龄化和生活方式的改变，NMIBC的发病率呈上升趋势。为了更好地了解NMIBC治疗者和患者目前面临的挑战，我们采用了混合方法，将二手研究与来自巴西、哥伦比亚、墨西哥和阿根廷的医疗服务提供者的定性访谈相结合。我们的分析发现，该地区仍然存在重大挑战，特别是由于卡介苗短缺、对临床指南的依从性不一致以及患者获得医疗服务方面存在巨大的社会经济差异。应对这些挑战需要加强患者宣传、战略性地利用临床试验以及更好地分配资源，以加强拉丁美洲对NMIBC的管理。
